Horizon Kinetics’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Horizon Kinetics’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$256K	Hold	19,000	–	–	0.01%	414
2018 Q3	$211K	Buy	+19,000	New	+$190K	0.01%	459
2017 Q1	–	Sell	-21,000	Closed	-$103K	–	520
2016 Q4	$103K	Hold	21,000	–	–	﹤0.01%	492
2016 Q3	$104K	Hold	21,000	–	–	﹤0.01%	497
2016 Q2	$107K	Hold	21,000	–	–	﹤0.01%	506
2016 Q1	$120K	Hold	21,000	–	–	﹤0.01%	505
2015 Q4	$218K	Hold	21,000	–	–	﹤0.01%	466
2015 Q3	$388K	Buy	21,000 +2,000	+11%	+$38.6K	0.01%	414
2015 Q2	$370K	Hold	19,000	–	–	0.01%	431
2015 Q1	$334K	Buy	19,000 +1,000	+6%	+$16.8K	﹤0.01%	447
2014 Q4	$288K	Hold	18,000	–	–	﹤0.01%	457
2014 Q3	$227K	Hold	18,000	–	–	﹤0.01%	477
2014 Q2	$281K	Hold	18,000	–	–	﹤0.01%	470
2014 Q1	$236K	Buy	18,000 +2,000	+13%	+$31.3K	﹤0.01%	489
2013 Q4	$257K	Hold	16,000	–	–	﹤0.01%	485
2013 Q3	$266K	Hold	16,000	–	–	﹤0.01%	474
2013 Q2	$161K	Buy	+16,000	New	+$168K	﹤0.01%	424

Other funds holding OSIR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Cloverdale Capital Management Dallas, Texas $135M AUM 13.89% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return

EGI

EAM Global Investors Solana Beach, California $34.8M AUM 275.91% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

Horizon Kinetics's OSIR Position: Q4 2018 in Review

Horizon Kinetics held its Osiris Therapeutics, Inc. Common Stock (OSIR) position steady in Q4 2018 at 19,000 shares worth $256K. The position accounts for 0.01% of the portfolio, ranked #414.

Horizon Kinetics first reported a position in OSIR in Q2 2013 and has held it in 17 quarters since. The position peaked at $388K in Q3 2015. 46 funds tracked by Wall St. Rank hold OSIR as of Q4 2018.

Horizon Kinetics held 19,000 shares of Osiris Therapeutics, Inc. Common Stock worth $256K as of Q4 2018.
Horizon Kinetics left its Osiris Therapeutics, Inc. Common Stock share count unchanged in Q4 2018.
Osiris Therapeutics, Inc. Common Stock made up 0.01% of Horizon Kinetics's portfolio in Q4 2018, its #414 holding.
Horizon Kinetics first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and has held it in 17 quarters since.
Horizon Kinetics's Osiris Therapeutics, Inc. Common Stock position peaked at $388K in Q3 2015.
46 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q4 2018.

Based on Horizon Kinetics's 13F filing for Q4 2018, filed 14 Feb 2019.